Home › Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101
 

Keywords :   


Ignyta Announces Initiation of STARTRK-1 Global Phase I/II Clinical Trial of RXDX-101

2014-07-21 15:41:01| Logistics - Topix.net

This clinical trial is called STARTRK-1, which stands for A/B/C, and is a Phase I/IIa, multicenter, single-arm, open-label clinical trial of continuous daily dosing of oral RXDX-101 in adult patients with locally advanced or metastatic cancer confirmed to be positive for relevant molecular alterations.

Tags: iii global trial phase

Category:Transportation and Logistics

Latest from this category

All news
29.09Tropical Storm Joyce Graphics
29.09Summary for Tropical Storm Joyce (AT1/AL112024)
29.09Tropical Storm Joyce Forecast Advisory Number 9
29.09Hurricane Isaac Graphics
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Atlantic Tropical Weather Outlook
29.09Eastern North Pacific Tropical Weather Outlook
29.09Hurricane Isaac Graphics
Transportation and Logistics »
29.09Rates low for too long, says ex-Bank of England boss
29.09Weekly Recap: Freudenberg Expands Coated Textiles Business, Trade Associations to Explore Alliance
29.09Tropical Storm Joyce Graphics
29.09Tropical Storm Joyce Forecast Advisory Number 9
29.09Summary for Tropical Storm Joyce (AT1/AL112024)
29.09Hurricane Isaac Graphics
29.09Summary for Hurricane Isaac (AT5/AL102024)
29.09Oasis ticket seller and promoter bosses get 14.8m
More »